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1. Abstract
1.1. Aims: Aim of this literature review was to analyse the world 
experience on COVID-19 patients who underwent surgical inter-
vention. Analyse the status of their peritoneal fluid and the surgical 
outcome in these COVID-19 patients.
1.2. Methods: Literature review of the published papers was per-
formed over the last two years. The studies involving patients who 
had COVID -19 confirmed by PCR results of nasopharyngeal 
swabs and underwent a surgical procedure and had the peritoneal 
fluid samples examined to detect the presence of the COVID 19 
virus.
1.3. Results: Ten papers assessing the COVID-19 in the peritoneal 
cavity were published, all of them were published in the year 2020. 
In all these studies total of 18 patients were confirmed COVID-19 
on nasopharyngeal PCR and these were Assessed for the detection 
of the COVID-19 in the peritoneal cavity. Three patients (3/18, 
16.6%) have no respiratory symptoms, fifteen (15/18, 83.33%) 
patients have respiratory symptoms. Seven patients (7/18, 38.8%) 
had COVID-19 detected in the peritoneum (Table 1), 2.dsa.
1.4. Conclusion: Patients with Respiratory symptoms are more 
likely to have peritoneal fluid positive for the disease. The overall 
mortality rate in patients with Pharyngeal PCR test +ve and who 
had surgical intervention is 9/18, 50%. Patients with Respiratory 
symptoms and positive Nasopharyngeal PCR had mortality rate 
of 8/9, 88.88% among those who died in this group. It is diffi-
cult to comment on the mortality and morbidity of patients with 
COVID-19 in the peritoneal fluids as number of cases is small and 
many other variables can influence the morbidity and mortality in 
this group. 
2. Introduction
The Corona virus causes respiratory infection, after 2-14 days of 
exposure symptoms like cough, fever, headache, myalgia and fa-
tigue appear. Corona belongs to RNA family of viruses. Covid-19 
is the new member of this family which surfaced in China in last 
months of 2019 [1]. During the early part of the COVID-19 pan-
demic new guidelines were formulated all over the world and 
implemented towards doctors, nurses, and healthcare workers in 
general, so that they can be protected from this life threatening 
infection while performing their duties in this COVID 19 pandem-
ic. The surgical theatres working conditions, importantly theatre 
protocols have changed significantly which have financial and 
practical implications. The new rules were introduced in order 
to minimise exposure of viruses to surgeons, nurses and all other 
health care workers in the operation theatres. As a result of this 
it has resulted in the testing of patients and medical staff in the 
operation.  The new guidelines were being quickly introduced and 
re updated rapidly to date by most international surgical societies, 
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to give surgical staff the most reliable and consistent guide lines 
while performing surgical cases which have potential or proved 
positive for COVID–19, especially in an emergency setting. [2, 3] 
It’s important to mention here that when first wave of COVID-19 
hit UK, all the elective surgeries except cancer surgeries were sus-
pended in most places. The health care workers were compelled 
to work in situations of uncertainty and high risk for more than a 
year and this was due to lack of relevant data about viral load in the 
various body compartments and fluids. [4,5] The excretion path 
mechanisms of COVID-19 were mostly unknown. We believe that 
our review of available literature on this topic of ‘‘Potential Infec-
tiousness of Peritoneal Secretions’’ will give important additional 
information from around the world on this burning topic which is 
still mystery for modern world of medical science [6].
3. Aim
Aim of this literature review was to analyse the world experience 
on COVID-19 patients who underwent surgical intervention. Fur-
thermore, to analyse the status of their peritoneal fluid and the sur-
gical outcome in these COVID-19 patients.
4. Methodology
Literature review of the published papers was performed over the 
last two years. The studies involving patients who had COVID -19 
confirmed by PCR results of nasopharyngeal swabs and underwent 
a surgical procedure and had the peritoneal fluid samples examined 
to detect the presence of the COVID 19 virus. Literature search 
was performed on Google and Pub Med using terms COVID19 
with bowel perforation, Bowel ischemia in COVID, Peritonitis in 
COVID 19, COVID 19 and Acute abdomen, COVID in Surgical 
patients, COVID as Surgical emergency, COVID and PCR from 
peritoneal cavity fluid. Ten papers were identified which assessed 
the COVID-19 in the peritoneal cavity and which were published 
in the years 2020 and 2021 (Table 1).
Table 1: The published papers assessing peritoneal cavity and peritoneal fluid
 Date of publication Corresponding author Title
1 May 2020 S. Flemming Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19
2 May 2020 Isaac José Felippe Corrêa Neto Perforated acute abdomen in a patient with COVID-19: an atypical manifestation of the disease
3 May2020 Edoardo Rimini COVID-19 in the peritoneal fluid: does this evidence oblige to introduce new rules? Presentation of a Case Report
4 Jun 2020 Barbara Seeliger Is the severe Acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) present intraperitoneally in patients with coronavirus disease 2019 (COVID-19) infection undergoing emergency operations?
5 Jul 2020 Victor C Passarelli Detection of SARS-CoV-2 in ascitic fluid: a case of viral peritonitis? 
6 Jul 2020 A. Barberis SARS-Cov-2 in peritoneal fluid: an important finding in the Covid-19 pandemic
7 Sep 2020 Saeed Safari Detection of SARS-CoV-2 in Abdominal and Adipose Tissues
8 Sep 2020 Federico Coccolini SARS-CoV-2 Is Present in Peritoneal Fluid in COVID-19 Patients
9 Sep 2020 Labib S. Al-Ozaibia Splenic Abscess: An Unusual Presentation of COVID-19?
10 Sep 2020 Margarita Ibarra-Hernandez
Detection of SARS-CoV-2 in peritoneal fluid from patients with kidney disease and COVID-19: 
report of two cases
5. Results
Ten papers assessing the COVID-19 in the peritoneal cavity were 
published, all of them were published in the year 2020 (Table 1). 
Out of total 18 patients, 9 males and 9 females. Maximum age was 
80 years and minimum age 30 years. Average age was 60.94 years 
(Table 1). In all these studies total of 18 patients were confirmed 
COVID-19 on nasopharyngeal PCR and these were assessed for 
the detection of the COVID-19 in the peritoneal cavity. Table 2.
Three patients (3/18, 16.6%) have no respiratory symptoms, fif-
teen (15/18, 83.33%) patients has respiratory symptoms (Table 
2). Seven patients (7/18, 38.8%) had COVID-19 detected in the 
peritoneum (Table 2). Rectal swab was taken in 6 patients and it 
was positive in 5 of them. Fifteen patients underwent different 
surgical interventions and two patients had peritoneal dialysis 
for renal disease while one patient had Paracentesis. Eight pa-
tients of them (8/18, 44.4%) had varying degree of GI Ischemia 
and underwent surgical interventions for that. Seven Patients had 
surgeries for other diagnosis rather than GI Ischemia while two 
patients underwent surgical interventions post abdominal trauma 
(Table 2). In our study seven patients out of eighteen (7/18, 38.8%) 
had COVID-19 detected in the peritoneal cavity. All these eigh-
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teen patients were also positive for COVID-19 on nasopharyngeal 
swab PCR test. It’s important to mention that all the patient who 
were positive for Covid-19 in the peritoneal cavity has respiratory 
symptoms as well 7/7, 100%. Which means patients with respira-
tory symptoms are more likely to have peritoneal fluid positive for 
the disease (Table 2).
Table 2: Analysis of the patient’s demography, intervention, outcome and PCR results from nasopharyngeal as well as the peritoneum
Sex Age Diagnosis Intervention Outcome Resp symptom
+ve PCR +ve PCR
N.pharngeal peritoneum
1.Male 75 Liver cirrhosis Paracentesis Died day 10 post diagnosis Yes Yes Yes
2.female 75 Empyema GB Lap Chole Died day 7post D No Yes No
3.Male 39 Small bowel perforation Resection and Anastomosis D/C home day 5 No Yes No
4.Male 32 Gangrenous appendicitis Lap Appendix D/C day 4 No yes No
5.Male 30 Perforated duodenal ulcer DU Repair Died day 7 Yes Yes No
6.Male 30 Acute cholecystitis Lap Cholecystectomy Day 5 D/C Yes Yes No
7.Male 56 Small bowel ischaemia Resection& Anastomosis Died Yes Yes No
8.Female 71 Appendicitis Lap Appendix Died D4 Yes Yes No
9.Female 70 Sigmoid ischemia Hartman’s Procedure D/C home D5 Yes Yes No
10.Male 44 Liver stabHaemo Peritoneum Wash out D3 D/C home Yes Yes No
11.Female 70 Haemo Peritonem Wash out Died Yes Yes No
12.Female 70 Intestinal bleeding Subtotal Colectomy Died day 7 Yes Yes Yes
13.Male 55 Splenic abscess Laparotomy& Drainage Died day16 Yes Yes No
14.Male 78 Small bowel obs/omental band Adhesiolysis D/C home D10 Yes Yes Yes
15.female 73 Umbilical hernia Resection/ Anastomosis D5 D/c home Yes Yes Yes
16.Female 80 Sigmoid Perforation Hartman’s Procedure Died D2 Yes Yes Yes
17.Female 71 End stage renal disease Peritoneal Dialysis D/C D8 home Yes Yes Yes
18.Female 78 End stage renal disease Peritoneal Dialysis D/C D13Home Yes Yes Yes
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The overall mortality rate in patients with Pharyngeal PCR test 
+ve only and who had surgical intervention is 9/18, 50%. Howev-
er, of these 9 patients, 8/9 (88.88%) patients who died had Respi-
ratory symptom and Pharyngeal PCR test +ve and whereas only 
1/9 (11.11%) patients died who had no Respiratory symptoms but 
only Pharyngeal PCR test +ve. Which means that among patient 
who died and who had Respiratory Symptoms and Positive Naso-
pharyngeal PCR have mortality rate of 8/9, 88.88% in this group 
Table 2. Furthermore, it is observed that among the patients who 
died 3/9, 33.3% had Peritoneal fluid positive for PCR test. It is 
also observed that total of 7 patients had all 3 tests positive (i.e. 
Respiratory symptoms, Nasopharyngeal PCR & Peritoneal PCR 
positive) and out of them 3 died which makes mortality rate in this 
group 3/7, 42.8%. Table 2.
6. Discussion
The COVID-19 virus enters the cells through the Angiotensin 
Converting Enzyme-2 receptor, which is not only expressed in 
pneumocytes (type II alveolar cells), but also expressed in the ep-
ithelium of the gastrointestinal tract, from the oesophagus to the 
colon, notably in ileal and colonic enterocytes also [7]. The cell 
membrane protein Angiotensin-Converting Enzyme 2 is key for 
receptor-mediated cell entry of SARS-CoV-2 (Severe Acute Re-
spiratory Syndrome Coronavirus 2) The GI tract can be damaged 
directly by the COVID-19 infection by the virus entry into the 
enterocytes or indirectly via the host inflammatory response [8]. 
The coronavirus through the tissue distribution, causes release of 
a high number of pro-inflammatory Cytokines which damages the 
micro vascular system, triggering abnormal activation of the co-
agulation system, which results generalized small-vessel vasculi-
tis and extensive micro thrombi [9, 10]. This phenomenon, along 
with the patient’s comorbidities, like hypertension and coronary 
disease, are linked with high mortality rates and a high risk of co-
agulation dysfunction. 
The ischemia of the whole digestive tract with or without perfora-
tion reported may be the outcome of the septic and thromboembol-
ic phenomena, resulted directly or indirectly by the viral infection. 
44.4% (8/18 patients) of the reported cases had varying degrees of 
bowel Ischemia. Studies have revealed that critically ill patients 
with COVID-19 are more prone to have a Hypercoagulable state, 
with the outcome of intravascular coagulation due to local damage 
[11, 12]. Table-2 SARS-CoV-2 RNA has been isolated in the blood 
and faeces of COVID-19 patients [13, 14]. In our study five out six 
patients were tested positive when they had rectal swabs. Some 
authors have conducted studies on peritoneal fluid in COVID-19 
positive patients, but without findings of the presence of the virus 
[15]. Table 2
The real-time reverse transcriptase–polymerase chain reaction 
used to identify the SARS-CoV-2 RNA genome in peritoneal fluid 
and nasal swabs. This identifies 3 targets, namely RNA-dependent 
RNA polymerase, nucleoprotein (N), and envelope (E) [16]. The 
peritoneal fluid was detected positive and at levels comparable 
to the nasal swab and even when retested in 10-fold diluted [16]. 
This establishes that the viral load in the peritoneal fluid was high-
er compared to the upper respiratory samples and concluded that 
the surgical operation was indeed a procedure at risk of infection. 
Viral isolation, which would have provided stronger evidence of 
infectivity, could not be performed. 
This expressed an important warning about the safety of the oper-
ating room staff and demanded an immediate update of the guide-
lines in order to protect surgical teams. Therefore, all the surgical 
procedures may risk the potential of aerosolization of the virus and 
the infection of the members of the surgical teams.
Laparoscopic or open surgical procedures both may result in gas/
vapour forming manoeuvre. Operating devices like electro cau-
tery, coagulation, and cutting devices produce gas and vapour 
which aerosolize the peritoneal fluid and consequently the virus. 
Activated Corneybacterium, human papillomavirus, hepatitis B 
virus, and human immunodeficiency virus have been detected in 
surgical smoke in the past [17]. Available literature has not shown 
direct relation between viremia and the severity of clinical picture. 
But in the presence of mild to moderate symptoms it is less likely 
to detect a positive viremia than in critically ill patients [18]. If 
we apply the same concept for the other body fluids, the greater 
the viremia, the higher the risks. As not much information avail-
able about the virus passage to peritoneal cavity and fluids, present 
data may suggest that potentially all people even those with mild 
to moderate respiratory symptoms by SARS-CoV-2 could pres-
ent viral load in peritoneal fluid, thus increasing the exposure and 
contagion risks for the entire surgical staff. There are inadequate 
guide lines available to protect the theatre staff from contagion 
peritoneal fluid as there is not much data supporting potential risks 
of peritoneal fluids. Few guide lines have recently come up in the 
literature to help doctors, surgeons and theatre staffs in their daily 
practice [19].
All the surgical staff should be trained and educated about the po-
tential risks of presence of COVID-19 in the peritoneal fluids and 
its potential to aerosolize to the environment from the peritoneal 
fluid in patients with SARS-CoV-2 [16].
7. Conclusion
Although there is limited data, but the percentages of detecting the 
COVID -19 in the peritoneum fluid is considerable. The overall 
mortality rate in patients with Pharyngeal PCR test +ve and who 
had surgical intervention is 9/18, 50%. Patients with Respiratory 
symptoms are more likely to get peritoneal fluid positive for the 
disease. Moreover patient who had Respiratory Symptoms and 
Positive Nasopharyngeal PCR have mortality rate of 8/9, 88.88% 
in this group Moreover it is difficult to comment on the exact mor-
tality and morbidity of patients with COVID-19 in the peritoneal 
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fluids as number is small in this study and many other variables 
can influence the morbidity and mortality in this group. However, 
this review of the literature is very informative for surgeons and 
other theatre staff for increasing their level of awareness and pro-
tection especially in emergency surgical setting.
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